Monitoring Direct Thrombin Inhibitors with Calibrated Diluted Thrombin Time versus Activated Partial Thromboplastin Time in Pediatric Patients

Online journal article in Hematopathology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

List clinical scenarios in which intravenous (IV) direct thrombin inhibitors (DTIs) are considered instead of heparin.
Describe limitations of activated...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

List clinical scenarios in which intravenous (IV) direct thrombin inhibitors (DTIs) are considered instead of heparin.
Describe limitations of activated partial thromboplastin time (aPTT) assays for monitoring patients receiving DTIs.
Compare results from assays using dilute thrombin time (dTT) with those using activated partial thromboplastin time (aPTT).

View More View Less